Case Report: Effective and Safe Treatment With Certolizumab Pegol in Pregnant Patients With Cogan’s Syndrome: A Report of Three Pregnancies in Two Patients
Authors:
Open Access
- 18 January 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 11
Abstract
Cogan’s syndrome is a rare autoimmune disease characterized by ocular inflammation and audiovestibular manifestations. Treatment consists of systemic glucocorticoids and other immunosuppressive agents including methotrexate, cyclophosphamide and TNF-α-inhibitors. Due to potential ovarian or fetal toxicity immunosuppressive treatment options are limited during pregnancies. Thus far there is a paucity of reports on pregnancies in Cogan’s syndrome. With minimal transplacental transfer, Certolizumab pegol is considered to be safe for the use in pregnant patients with underlying inflammatory diseases. However, there is no literature on the use of this TNF-α-inhibitor in Cogan’s syndrome in general and especially during gestation. Here we report three pregnancies in two Cogan’s Syndrome-patients treated with Certolizumab pegol. Treatment with Certolizumab pegol was effective and well tolerated in patients with Cogan’s syndrome and seems to be a safe treatment option during pregnancy.Keywords
This publication has 12 references indexed in Scilit:
- Lack of placental transfer of certolizumab pegol during pregnancy: results from CRIB, a prospective, postmarketing, pharmacokinetic studyAnnals of the Rheumatic Diseases, 2018
- Cogan syndrome: Characteristics, outcome and treatment in a French nationwide retrospective study and literature reviewAutoimmunity Reviews, 2017
- Minimal to no transfer of certolizumab pegol into breast milk: results from CRADLE, a prospective, postmarketing, multicentre, pharmacokinetic studyAnnals of the Rheumatic Diseases, 2017
- Cogan's syndrome: State of the art of systemic immunosuppressive treatment in adult and pediatric patientsAutoimmunity Reviews, 2017
- The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactationAnnals of the Rheumatic Diseases, 2016
- Cogan Syndrome in PregnancyObstetrics & Gynecology, 2014
- Rheumatoid arthritis and pregnancy: evolution of disease activity and pathophysiological considerations for drug useRheumatology, 2011
- Cogan's syndrome complicating pregnancyThe Journal of Maternal-Fetal & Neonatal Medicine, 2009
- Successful full-term pregnancy in a woman with Cogan’s syndrome: a case reportClinical Rheumatology, 2007
- SYNDROME OF NONSYPHILITIC INTERSTITIAL KERATITIS AND VESTIBULOAUDITORY SYMPTOMSArchives of Ophthalmology (1950), 1945